Compare CLMT & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLMT | OPCH |
|---|---|---|
| Founded | 1916 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Nursing Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2024 | 1996 |
| Metric | CLMT | OPCH |
|---|---|---|
| Price | $59.01 | $24.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $28.65 | ★ $36.57 |
| AVG Volume (30 Days) | 1.1M | ★ 1.8M |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.39 | 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | $4,137,100,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $3.94 | $7.21 |
| Revenue Next Year | $1.07 | $8.55 |
| P/E Ratio | ★ N/A | $83.53 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $17.42 | $18.01 |
| 52 Week High | $59.67 | $36.80 |
| Indicator | CLMT | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 75.69 | 56.65 |
| Support Level | $30.74 | $22.97 |
| Resistance Level | N/A | $24.70 |
| Average True Range (ATR) | 2.31 | 0.63 |
| MACD | 0.32 | 0.01 |
| Stochastic Oscillator | 92.77 | 62.24 |
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.